These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7421170)

  • 1. Oxidative metabolism in experimental Bacteriodies fragilis bactermia.
    Fry DE; Kaelin CR; Rink RD
    J Surg Res; 1980 Jun; 28(6):501-6. PubMed ID: 7421170
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of pure or combined inocula of Escherichia coli and Bacteroides fragilis on the liver and related metabolism.
    Rink RD; Kaelin CR; Raque G; Trachtenberg LS; Fry DE
    Lab Invest; 1982 Mar; 46(3):282-7. PubMed ID: 7038296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of live Escherichia coli and Bacteroides fragilis on metabolism and hepatic pO2.
    Rink RD; Kaelin CR; Giammara B; Fry DE
    Circ Shock; 1981; 8(5):601-11. PubMed ID: 7026081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Bacteroides fragilis toxin by a novel bacterial protease contributes to anaerobic sepsis in mice.
    Choi VM; Herrou J; Hecht AL; Teoh WP; Turner JR; Crosson S; Bubeck Wardenburg J
    Nat Med; 2016 May; 22(5):563-7. PubMed ID: 27089515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth of Bacteroides fragilis in rabbit tracheal organ culture: anaerobiosis and tissue respiration.
    Murakami T; Matsuyama T; Shiraishi S; Hagihara B
    Infect Immun; 1981 Dec; 34(3):1062-4. PubMed ID: 7333664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of anaerobic bacteria in intra-abdominal septic abscesses in mediating septic control of skeletal muscle glucose oxidation and lactic acidemia.
    Vary TC; Siegel JH; Tall B; Morris JG
    J Trauma; 1989 Jul; 29(7):1003-13; discussion 1013-4. PubMed ID: 2664200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity of the Bacteroides fragilis group.
    Brook I
    Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
    Kasper DL; Onderdonk AB
    Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bacteroides fragilis cell envelope: quarterback, linebacker, coach-or all three?
    Pumbwe L; Skilbeck CA; Wexler HM
    Anaerobe; 2006; 12(5-6):211-20. PubMed ID: 17045496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of chronic bacteremia on the metabolic response to exercise in the conscious rat.
    Musch TI; Martin LF
    Circ Shock; 1988 Aug; 25(4):245-58. PubMed ID: 3048770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteroides fragilis interferes with iNOS activity and leads to pore formation in macrophage surface.
    Vieira JM; Vallim DC; Ferreira EO; Seabra SH; Vommaro RC; Avelar KE; De Souza W; Ferreira MC; Domingues RM
    Biochem Biophys Res Commun; 2005 Jan; 326(3):607-13. PubMed ID: 15596142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of oxygen metabolism in experimental bacteremia.
    Fry DE; Kaelin CR; Giammara BL; Rink RD
    Adv Shock Res; 1981; 6():45-54. PubMed ID: 6130696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic and systemic metabolic responses to aerobic and anaerobic intra-abdominal abscesses in a highly reproducible chronic rat model.
    Nakatani T; Sato T; Marzella L; Hirai F; Trump BF; Siegel JH
    Circ Shock; 1984; 13(3):271-94. PubMed ID: 6380793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative metabolism in rat hepatocytes and mitochondria during sepsis.
    Kantrow SP; Taylor DE; Carraway MS; Piantadosi CA
    Arch Biochem Biophys; 1997 Sep; 345(2):278-88. PubMed ID: 9308900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro selection of ertapenem and piperacillin/tazobactam-resistant strains of Bacteroides fragilis and analysis of their virulence in gnotobiotic mice.
    Valéria Dos Santos K; Roque DE Carvalho MA; Amancio Martins W; Coutinho SC; Bahia JL; Lopes DE Andrade JP; Morais Apolonio AC; Cara DC; Galuppo Diniz C; Nicoli JR; DE Macedo Farias L
    J Chemother; 2010 Aug; 22(4):259-63. PubMed ID: 20685630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of the effect of anti-anaerobic drugs in experimental Bacteroides fragilis infection in mice.
    Dijkmans BA; Mattie H; Hermans J; van Furth R
    J Antimicrob Chemother; 1984 Jan; 13(1):79-86. PubMed ID: 6365877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell proliferative responses following sepsis in neonatal rats.
    Dallal O; Ravindranath TM; Choudhry MA; Kohn A; Muraskas JK; Namak SY; Alattar MH; Sayeed MM
    Biol Neonate; 2003; 83(3):201-7. PubMed ID: 12660439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose utilisation in the lungs of septic rats.
    Hansson L; Ohlsson T; Valind S; Sandell A; Luts A; Jeppsson B; Wollmer P
    Eur J Nucl Med; 1999 Oct; 26(10):1340-4. PubMed ID: 10541834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for enterotoxigenic Bacteroides fragilis in stool samples.
    Keenan JI; Aitchison A; Purcell RV; Greenlees R; Pearson JF; Frizelle FA
    Anaerobe; 2016 Aug; 40():50-3. PubMed ID: 27166180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteraemia and seeding of capsulate Bacteroides spp. and anaerobic cocci.
    Brook I
    J Med Microbiol; 1987 Feb; 23(1):61-7. PubMed ID: 3820272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.